Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases

Neurochem Res. 2022 May;47(5):1125-1149. doi: 10.1007/s11064-021-03521-9. Epub 2022 Jan 4.

Abstract

It is considered a significant challenge to understand the neuronal cell death mechanisms with a suitable cure for neurodegenerative disorders in the coming years. Calpains are one of the best-considered "cysteine proteases activated" in brain disorders. Calpain is an important marker and mediator in the pathophysiology of neurodegeneration. Calpain activation being the essential neurodegenerative factor causing apoptotic machinery activation, it is crucial to develop reliable and effective approaches to prevent calpain-mediated apoptosis in degenerating neurons. It has been recently seen that the "inhibition of calpain activation" has appeared as a possible therapeutic target for managing neurodegenerative diseases. A systematic literature review of PubMed, Medline, Bentham, Scopus, and EMBASE (Elsevier) databases was conducted. The present article reviews the basic pathobiology and role of selective calpain inhibitors used in various neurodegenerative diseases as a therapeutic target.

Keywords: Apoptosis; Calpain; Calpain inhibitors; Neurodegenerative disease; Pathophysiology.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Apoptosis
  • Calpain / physiology
  • Humans
  • Neurodegenerative Diseases* / drug therapy

Substances

  • calpain inhibitors
  • Calpain